Overall, tilianin suppresses NLRP3 inflammasome activation in myocardial ischemia/reperfusion injury by inhibiting the TLR4/NF-κB and NEK7/NLRP3 pathways. This evidence concerns the gene TLR4 and myocardial ischemia.